Collectively, these studies demonstrate that an intrinsic increase in the expression of AhR and its activity through endogenous and exogenous ligand factors has the potential to exert multifaceted influences on the pathophysiology of metabolic disorders, including DM. The gene discussed is AHR; the disease is Other metabolic disease.